AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By Treatment Type, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5主要研究的细节
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 AI In Oncology Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1父市场
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.2 Market restraint analysis
3.3 Penetration & Growth Prospect Mapping
3.4 AI In Oncology: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
Chapter 4 AI In Oncology Market Segment Analysis, By Component, 2016 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Component Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global AI In Oncology Market, by Component, 2016 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2016 to 2030
4.5.1 Software Solutions
4.5.1.1 Software solutions market estimates and forecast, 2016 - 2030 (USD Million)
4.5.2 Hardware
4.5.2.1 Hardware market estimates and forecast, 2016 - 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 5 AI In Oncology Market Segment Analysis, By Cancer Type, 2016 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Cancer Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global AI In Oncology Market, by Cancer Type, 2016 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2030
5.5.1 Breast Cancer
5.5.1.1 Breast cancer market estimates and forecast, 2016 - 2030 (USD Million)
5.5.2 Lung Cancer
5.5.2.1 Lung cancer market estimates and forecast, 2016 - 2030 (USD Million)
5.5.3 Prostate Cancer
5.5.3.1 Prostate cancer market estimates and forecast, 2016 - 2030 (USD Million)
5.5.4 Colorectal Cancer
5.5.4.1 Colorectal cancer market estimates and forecast, 2016 - 2030 (USD Million)
5.5.5 Brain Tumor
5.5.5.1 Brain tumor market estimates and forecast, 2016 - 2030 (USD Million)
5.5.6 Others
5.5.6.1 Others market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 6 AI In Oncology Market Segment Analysis, By Treatment Type, 2016 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Age Group Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global AI In Oncology Market, by Treatment Type, 2016 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2030
6.5.1 Chemotherapy
6.5.1.1 Chemotherapy market estimates and forecast, 2016 - 2030 (USD Million)
6.5.2 Radiotherapy
6.5.2.1 Radiotherapy market estimates and forecast, 2016 - 2030 (USD Million)
6.5.3 Immunotherapy
6.5.3.1 Immunotherapy market estimates and forecast, 2016 - 2030 (USD Million)
6.5.4 Others
6.5.4.1 Others market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 7 AI In Oncology Market Segment Analysis, By Region, 2016 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East & Africa
7.6 AI In Oncology Market Share by Region, 2022 & 2030
7.7 North America
7.7.1 North America AI in oncology market, 2016 - 2030 (USD Million)
7.7.2 U.S.
7.7.2.1 U.S. AI in oncology market, 2016 - 2030 (USD Million)
7.7.3 Canada
7.7.3.1 Canada AI in oncology market, 2016 - 2030 (USD Million)
7.8欧洲
7.8.1 Europe AI in oncology market, 2016 - 2030 (USD Million)
7.8.2英国
7.8.2.1 U.K. AI in oncology market, 2016 - 2030 (USD Million)
7.8.3 Germany
7.8.3.1 Germany AI in oncology market, 2016 - 2030 (USD Million)
7.8.4 France
7.8.4.1 France AI in oncology market, 2016 - 2030 (USD Million)
7.8.5 Italy
7.8.5.1 Italy AI in oncology market, 2016 - 2030 (USD Million)
7.8.6. Spain
7.8.6.1 Spain AI in oncology market, 2016 - 2030 (USD Million)
7.8.7 Denmark
7.8.7.1 Denmark AI in oncology market, 2016 - 2030 (USD Million)
7.8.8 Sweden
7.8.8.1 Sweden AI in oncology market, 2016 - 2030 (USD Million)
7.8.9 Norway
7.8.9.1 Norway AI in oncology market, 2016 - 2030 (USD Million)
7.9 Asia Pacific
7.9.1 Asia Pacific AI in oncology market, 2016 - 2030 (USD Million)
7.9.2 China
7.9.2.1 China AI in oncology market, 2016 - 2030 (USD Million)
7.9.3 Japan
7.9.3.1 Japan AI in oncology market, 2016 - 2030 (USD Million)
7.9.4 India
7.9.4.1 India AI in oncology market, 2016 - 2030 (USD Million)
7.9.5 South Korea
7.9.5.1 South Korea AI in oncology market, 2016 - 2030 (USD Million)
7.9.6. Australia
7.9.6.1 Australia AI in oncology market, 2016 - 2030 (USD Million)
7.9.7 Thailand
7.9.7.1 Thailand AI in oncology market, 2016 - 2030 (USD Million)
7.10 Latin America
7.10.1 Latin America AI in oncology market, 2016 - 2030 (USD Million)
7.10.2 Brazil
7.10.2.1 Brazil AI in oncology market, 2016 - 2030 (USD Million)
7.10.3 Mexico
7.10.3.1 Mexico AI in oncology market, 2016 - 2030 (USD Million)
7.10.4 Argentina
7.10.4.1 Argentina AI in oncology market, 2016 - 2030 (USD Million)
7.11 MEA
7.11.1 MEA AI in oncology market, 2016 - 2030 (USD Million)
7.11.2 South Africa
7.11.2.1 South Africa AI in oncology market, 2016 - 2030 (USD Million)
7.11.3 Saudi Arabia
7.11.3.1 South Africa AI in oncology market, 2016 - 2030 (USD Million)
7.11.4 UAE
7.11.4.1 South Africa AI in oncology market, 2016 - 2030 (USD Million)
7.11.5 Kuwait
7.11.5.1 South Africa AI in oncology market, 2016 - 2030 (USD Million)
Chapter 8 AI In Oncology Market - Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Company Categorization
8.3 Company Profiles
8.3.1 Azra AI
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 IBM
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Siemens Healthcare GmbH
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Intel Corporation
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 GE HealthCare
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3产品基准测试
8.3.5.4 Strategic Initiatives
8.3.6 NVIDIA Corporation,
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Digital Diagnostics Inc.
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 ConcertAI
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Median Technologies
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 PathAI
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global AI In Oncology Market, By Region, 2016 - 2030 (USD Million)
Table 4 Global AI In Oncology Market, By Component, 2016 - 2030 (USD Million)
Table 5 Global AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 6 Global AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 7 North America AI In Oncology Market, By Country, 2016 - 2030 (USD Million)
Table 8 North America AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 9 North America AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 10 North America AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 11 AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 12 AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 13 AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 14 Canada AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 15 Canada AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 16 Canada AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 17 Europe AI In Oncology Market, By Country, 2016 - 2030 (USD Million)
Table 18 Europe AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 19 Europe AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 20 Europe AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 21 UK AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 22 UK AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 23 UK AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 24 Germany AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 25 Germany AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 26 Germany AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 27 France AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 28 France AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 29 France AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 30 Italy AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 31 Italy AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 32 Italy AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 33 Spain AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 34 Spain AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 35 Spain AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 36 Denmark AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 37 Denmark AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 38 Denmark AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 39 Norway AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 40 Norway AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 41 Norway AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 42 Sweden AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 43 Sweden AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 44 Sweden AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 45 Asia Pacific AI In Oncology Market, By Country, 2016 - 2030 (USD Million)
Table 46 Asia Pacific AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 47 Asia Pacific AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 48 Asia Pacific AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 49 Japan AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 50 Japan AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 51 Japan AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 52 China AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 53 China AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 54 China AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 55 India AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 56 India AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 57 India AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 58 South Korea AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 59 South Korea AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 60 South Korea AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 61 Australia AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 62 Australia AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 63 Australia AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 64 Thailand AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 65 Thailand AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 66 Thailand AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 67 Latin America AI In Oncology Market, By Country, 2016 - 2030 (USD Million)
Table 68 Latin America AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 69 Latin America AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 70 Latin America AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 71 Brazil AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 72 Brazil AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 73 Brazil AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 74 Argentina AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 75 Argentina AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 76 Argentina AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 77 Mexico AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 78 Mexico AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 79 Mexico AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
表80年中东和非洲AI Oncology Market, By Country, 2016 - 2030 (USD Million)
Table 81 Middle East and Africa AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 82 Middle East and Africa AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 83 Middle East and Africa AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 84 South Africa AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 85 South Africa AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 86 South Africa AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 87 Saudi Arabia AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 88 Saudi Arabia AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 89 Saudi Arabia AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 90 UAE AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 91 UAE AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 92 UAE AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)
Table 93 Kuwait AI In Oncology Market, By Component Type, 2016 - 2030 (USD Million)
Table 94 Kuwait AI In Oncology Market, By Cancer Type, 2016 - 2030 (USD Million)
Table 95 Kuwait AI In Oncology Market, By Treatment Type, 2016 - 2030 (USD Million)

List of Figures

Fig. 1 AI in oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
图16 AI肿瘤市场:组件类型ment analysis
Fig. 17 AI in oncology market: Component type segment dashboard
Fig. 18 AI in oncology market component type outlook: Key takeaways
Fig. 19 Software solutions market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 20 Hardware market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 21 Software market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 22 AI in oncology market: Cancer Type movement analysis
图23 AI在肿瘤市场:癌症类型dashboard
Fig. 24 AI in oncology market cancer type outlook: Key takeaways
Fig. 25 Breast cancer market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 26 Lung cancer market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 27 Prostate cancer market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 28 Colorectal cancer market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 29 Brain tumour market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 31 AI in oncology market: Treatment type movement analysis
Fig. 32 AI in oncology market: Treatment type segment dashboard
Fig. 33 AI in oncology market treatment type outlook: Key takeaways
Fig. 34 Chemotherapy market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 35 Radiotherapy market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 36 Immunotherapy market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 38 Regional outlook, 2022 & 2030
Fig. 39 Regional market dashboard
Fig. 40 Regional market place: Key takeaways
Fig. 41 North America, SWOT
Fig. 42 Europe, SWOT
Fig. 43 Asia Pacific, SWOT
Fig. 44 Latin America, SWOT
Fig. 45 Middle East and Africa, SWOT
Fig. 46 North America
Fig. 47 North America AI in oncology market, 2016 - 2030 (USD Million)
Fig. 48 U.S.
Fig. 49 U.S. AI in oncology market, 2016 - 2030 (USD Million)
Fig. 50 Canada
Fig. 51 Canada AI in oncology market, 2016 - 2030 (USD Million)
Fig. 52 Europe
Fig. 53 Europe AI in oncology market, 2016 - 2030 (USD Million)
Fig. 54 UK.
Fig. 55 UK AI in oncology market, 2016 - 2030 (USD Million)
Fig. 56 Germany
Fig. 57 Germany AI in oncology market, 2016 - 2030 (USD Million)
Fig. 58 Spain
Fig. 59 Spain AI in oncology market, 2016 - 2030 (USD Million)
Fig. 60 France
Fig. 61 France AI in oncology market, 2016 - 2030 (USD Million)
Fig. 62 Italy
Fig. 63 Italy AI in oncology market, 2016 - 2030 (USD Million)
Fig. 64 Denmark
Fig. 65 Denmark AI in oncology market, 2016 - 2030 (USD Million)
Fig. 66 Norway
Fig. 67 Norway AI in oncology market, 2016 - 2030 (USD Million)
Fig. 68 Sweden
Fig. 69 Sweden AI in oncology market, 2016 - 2030 (USD Million)
Fig. 70 Asia Pacific
Fig. 71 Asia Pacific AI in oncology market, 2016 - 2030 (USD Million)
Fig. 72 Japan
Fig. 73 Japan AI in oncology market, 2016 - 2030 (USD Million)
Fig. 74 China
图75年中国人工智能在肿瘤市场,2016 - 2030 (USD Million)
Fig. 76 India
Fig. 77 India AI in oncology market, 2016 - 2030 (USD Million)
Fig. 78 South Korea
Fig. 79 South Korea AI in oncology market, 2016 - 2030 (USD Million)
Fig. 80 Australia
Fig. 81 Australia AI in oncology market, 2016 - 2030 (USD Million)
Fig. 82 Thailand
Fig. 83 Thailand AI in oncology market, 2016 - 2030 (USD Million)
Fig. 84 Latin America
Fig. 85 Latin America AI in oncology market, 2016 - 2030 (USD Million)
Fig. 86 Brazil
Fig. 87 Brazil AI in oncology market, 2016 - 2030 (USD Million)
Fig. 88 Mexico
Fig. 89 Mexico AI in oncology market, 2016 - 2030 (USD Million)
Fig. 90 Argentina
Fig. 91 Argentina AI in oncology market, 2016 - 2030 (USD Million)
Fig. 92 Middle East and Africa
Fig. 93 MEA AI in oncology market, 2016 - 2030 (USD Million)
Fig. 94 South Africa
Fig. 95 South Africa AI in oncology market, 2016 - 2030 (USD Million)
Fig. 96 Saudi Arabia
Fig. 97 Saudi Arabia AI in oncology market, 2016 - 2030 (USD Million)
Fig. 98 UAE
Fig. 99 UAE AI in oncology market, 2016 - 2030 (USD Million)
Fig. 100 Kuwait
Fig. 101 Kuwait AI in oncology market, 2016 - 2030 (USD Million)